ThinkSabio

$AKBA

$0.96▲ +1.1% YTD

2 SEC 13D/G filings tracked · Last updated Sep 14, 2026

Filing History
News
AKBA ▲ +1.1% - Akebia Therapeutics, Inc.
CP $0.96▲ +1.1%Sep 14, 2026 · ThinkSabio Blog

$AKBA - Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases…

News
AKBA ▲ +3.3% - Akebia Therapeutics, Inc.
CP $0.95▲ +3.3%Sep 1, 2026 · ThinkSabio Blog

$AKBA - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…